Life Spine receives additional US FDA clearance for the PROLIFT expandable system

1798
Life Spine has developed the ProLift expandable spacer system
Life Spine has developed the ProLift expandable spacer system

Life Spine has received an additional clearance from the US Food and Drug Administration (FDA) to market the Lateral PROLIFT expandable system. The company also announced that they are slated to launch 20 new products, including six micro invasive expandables, in 2020.

“This year we will add some pivotal new technologies to our already robust expandable portfolio bringing our total number of expandable devices to 13,” said Rich Mueller, Chief Operating Officer for Life Spine. “Investing in expandable technologies is important to us because expandables are designed to allow for a truly Micro Invasive procedure by going in small and opening to match each patient’s unique anatomy. Our dedication to offering expandable solutions dates back to 2006 when we filed our first patent around expandable technology and now we aim to file one patent each month.”

Life Spine’s current expandable portfolio includes the lateral PROLIFT expandable system, 10mm and 12mm PROLIFT Expandable Systems for TLIF and PLIF approaches, the AILERON TRX expandable interspinous spacer, the LONGBOW expandable lateral spacer system, the LONGBOW expandable TLIF spacer system and the TiBOW expandable spacer system with horizontal expansion for a TLIF approach.


LEAVE A REPLY

Please enter your comment!
Please enter your name here